Find generic entry opportunities
Proactively manage your pharmacy inventory
Drug patents …
… from Kazakhstan to Kalamazoo
Anticipate generic drug launch
Manage your formulary budget
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
|Title:||Dibenz[b,e]oxepin derivative and pharmaceutical compositions thereof|
|Abstract:||Novel dibenz[b,e]oxepin derivatives are employed in the treatment and control of allergic conditions such as allergic asthma and also employed in the treatment of inflammation.|
|Inventor(s):||Oshima; Etsuo (Shizuoka, JP), Kumazawa; Toshiaki (Shizuoka, JP), Otaki; Shizuo (Shizuoka, JP), Obase; Hiroyuki (Shizuoka, JP), Ohmori; Kenji (Mishima, JP), Ishii; Hidee (Shizuoka, JP), Manabe; Haruhiko (Shizuoka, JP), Tamura; Tadafumi (Shizuoka, JP), Shuto; Katsuichi (Shizuoka, JP)|
|Assignee:||Kyowa Hakko Kogyo Co., Ltd. (Tokyo, JP)|
Patent Claim Types:|
see list of patent claims
|Foriegn Application Priority Data|
|Foreign Country||Foreign Patent Number||Foreign Patent Date|
|Japan||61-45676||Mar 03, 1986|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|European Patent Office||0235796||► subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.